Drawing for OBSIDIO

USPTO serial 97646307

OBSIDIO

Reviewed by CopyMark Law Group

Reg. 7681108Status 700Registered
Filing date
Status date
Registration date
Feb 4, 2025
Examiner
DAWE III, WILLIAM H
Law office
PUBLICATION AND ISSUE SECTION

What this means

Status 700 means the trademark is registered and active on the Principal Register. You have nationwide rights for the listed goods and services and may use ®. Section 8 maintenance is due between years five and six. Calendar Section 8 between years five and six, and consider trademark monitoring.

Status 700: Status 700 means the trademark is registered and active on the Principal Register. You have nationwide rights for the listed goods and services and may use ®. Section 8 maintenance is due between years five and six.

Need help with OBSIDIO?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

Lori A. Ruhly

Lori A. Ruhly Quarles & Brady LLP33 East Main Street, Suite 900Madison, WI 53703United States

Goods and services

ClassDescriptionStatusFirst use
005Pharmaceutical preparations for implantable hydrogel-based embolics; pharmaceutical preparations, namely, embolization therapy preparations for embolization of tumors; medical preparations for embolization therapy systems for the treatment of hypervascular tumors and blood vessels to stop blood flow and control bleeding and hemorrhaging; medical preparations for vascular embolization, hemorrhage control, and peripheral hemostasis; medical preparations used for embolization of vascular lesions, tumors, targeted arterial segments of hypervascular tumors, control of bleeding due to disease or trauma, organs and segmental embolizations; pharmaceutical preparations, namely, differentiated liquid embolic agents for embolization of hypervascular tumors and blood vessels to stop blood flow and control bleeding and hemorrhaging; pharmaceutical preparations for medical and surgical purposes in the nature of implantable materials comprised of artificial materials, namely, hydrogels; pharmaceutical preparations for embolization therapy in interventional radiology and oncology in the nature of implants comprised of artificial materials, namely, hydrogels; medical preparations for embolization therapy in interventional radiology and oncology in the nature of implants comprised of artificial materials, namely, hydrogels; preparations for implantable surgical materials in the nature of implants comprised of artificial materials, namely, hydrogelsACTIVE—
010Surgical and medical apparatus and instruments for use in general surgery; medical apparatus and instruments for use in embolization surgery; medical device, namely, arterial embolectomy device in the nature of catheters for use in embolectomy; medical device for embolization therapy in interventional radiology and oncology; embolic devices for interventional radiology, namely, interventional oncology and peripheral hemostasis; medical device for vascular embolization procedures; medical device used for embolization of vascular lesions, tumors, targeted arterial segments of hypervascular tumors, control of bleeding due to disease or trauma, organs and segmental embolizations; medical devices, namely, syringes and delivery catheters for the delivery of embolic agents delivered through a microcatheter under fluoroscopic control; medical apparatus, namely, system for vascular embolization procedures in the nature of catheters for use in embolectomyACTIVE—

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
Feb 4, 2025NRCCNOTICE OF REGISTRATION CONFIRMATION EMAILED—
Feb 4, 2025R.PRREGISTERED-PRINCIPAL REGISTERYour trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive.
Jan 14, 2025SUNANOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED—
Jan 14, 2025CNPRALLOWED PRINCIPAL REGISTER - SOU ACCEPTED—
Jan 14, 2025TEMETEAS/EMAIL CORRESPONDENCE ENTERED—
Jan 14, 2025CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Jan 13, 2025ALIEASSIGNED TO LIE—
Dec 12, 2024TROATEAS RESPONSE TO OFFICE ACTION RECEIVEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Sep 16, 2024GNRNNOTIFICATION OF NON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Sep 16, 2024GNRTNON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Sep 16, 2024CNRTSU - NON-FINAL ACTION - WRITTENA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Sep 13, 2024SUPCSTATEMENT OF USE PROCESSING COMPLETE—
Sep 11, 2024AITUCASE ASSIGNED TO INTENT TO USE PARALEGAL—
Sep 3, 2024TCCATEAS CHANGE OF CORRESPONDENCE RECEIVED—
Sep 3, 2024ARAAATTORNEY/DOM.REP.REVOKED AND/OR APPOINTEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Sep 3, 2024REAPTEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED—
Sep 3, 2024CHANAPPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED—
Sep 3, 2024COARTEAS CHANGE OF OWNER ADDRESS RECEIVED—
Jul 10, 2024IUAFUSE AMENDMENT FILED—
Jul 10, 2024EISUTEAS STATEMENT OF USE RECEIVEDThe applicant filed a Statement of Use with specimens showing the mark in actual commerce. The USPTO will review the filing for compliance. If accepted, the mark can proceed to registration; if deficient, the USPTO may issue a requirement or office action.
Jan 16, 2024NOAMNOA E-MAILED - SOU REQUIRED FROM APPLICANTA Notice of Allowance means your intent-to-use application cleared examination and opposition but is not registered yet. You must file a Statement of Use showing the mark in commerce, or request an extension, before the deadline — usually six months from the notice date.
Nov 21, 2023NPUBOFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED—
Nov 21, 2023PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
Nov 1, 2023NONPNOTIFICATION OF NOTICE OF PUBLICATION E-MAILED—
Oct 12, 2023CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
Oct 4, 2023TEMETEAS/EMAIL CORRESPONDENCE ENTERED—
Oct 4, 2023CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Oct 4, 2023TROATEAS RESPONSE TO OFFICE ACTION RECEIVEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Jul 13, 2023GNRNNOTIFICATION OF NON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Jul 13, 2023GNRTNON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Jul 13, 2023CNRTNON-FINAL ACTION WRITTENA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Jul 12, 2023DOCKASSIGNED TO EXAMINER—
Mar 16, 2023CHANAPPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED—
Mar 16, 2023TCCATEAS CHANGE OF CORRESPONDENCE RECEIVED—
Mar 16, 2023ARAAATTORNEY/DOM.REP.REVOKED AND/OR APPOINTEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Mar 16, 2023REAPTEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED—
Mar 16, 2023COARTEAS CHANGE OF OWNER ADDRESS RECEIVED—
Nov 8, 2022NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED—
Oct 28, 2022NWAPNEW APPLICATION ENTERED—

Frequently asked questions

Related guidance